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Abstract
Background -: Rabbits provide an excellent model for many animal and human diseases, such as cardiovascular
diseases, for the development of new vaccines in wound healing management and in the field of tissue engineering
of tendon, cartilage, bone and skin.
The study presented herein aims to investigate the biological properties of bone marrow rabbit MSCs cultured
in different conditions, in order to provide a basis for their clinical applications in veterinary medicine.
Findings -: MSCs were isolated from 5 New Zealand rabbits. Fold increase, CFU number, doubling time,
differentiation ability and immunophenotype were analyzed.
With the plating density of 10 cells/cm2 the fold increase was significantly lower with DMEM-20%FCS and MSCs
growth was significantly higher with αMEM-hEGF. The highest clonogenic ability was found at 100 cell/cm2 with
MSCBM and at 10 cell/cm2 with M199. Both at 10 and 100 cells/cm2, in αMEM medium, the highest CFU increase
was obtained by adding bFGF. Supplementing culture media with 10%FCS-10%HS determined a significant
increase of CFU.
Conclusion -: Our data suggest that different progenitor cells with differential sensitivity to media, sera and
growth factors exist and the choice of culture conditions has to be carefully considered for MSC management.
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Background
Bone marrow contains at least two major stem cell line-
ages, hematopoietic [1,2] and mesenchymal (stromal)
cells [3-5]. A standard in vitro assay for bone marrow stro-
mal cell activity is the Fibroblastic Colony-Forming Unit
(CFU-F) assay in which adherent fibroblastic cells are cul-
tured by plating bone marrow cells either directly or fol-
lowing gradient separation [6]. The phenotype of these
cells appears to vary depending on the culture conditions
and the specific cell preparation [7,8]. Typically a broad
range of colony sizes has been obtained, with varying
growth rates and different cell morphologies [9], probably
reflecting the presence of a mixed population of multi-,
bi-, and unipotential progenitors [10,11], whose features
and biological properties have been only partially investi-
gated.
The aim of the present study was to compare the basic bio-
logical properties of the cells obtained with different cul-
ture media, supplements, and protocols of rabbit
Mesenchymal Stem Cell (rMSC) culture, in order to estab-
lish the optimal culturing conditions thus providing a
basis for further studies on the biological heterogeneity of
rMSC.
Methods
Isolation, expansion and differentiation of rMSC
Five New Zealand female rabbits were included in the
study under guidelines determined by the Local Ethical
Committee.
Five mL samples of bone marrow aspirates from femur
were drawn and treated to induce haemolysis. The
remaining nucleated cell suspensions were centrifuged at
500 g for 10 minutes and the pellets were resuspended in
low glucose DMEM supplemented with 10% fetal calf
serum (FCS), 10 U/mL penicillin G, 10 μg/mL streptomy-
cin, 2 mM L-glutamine.
Cells were counted and resuspended in standard culture
medium (SCM): α-MEM, 20% FCS, 100 U/mL penicillin,
100 μg/mL streptomycin, 2 mM L-glutamine. Plating con-
centration was 105cells/cm2 in 25 cm2 tissue culture flasks.
After 24 hours the non adherent cells were removed by
washing with PBS. Fresh SCM was added twice a week up
to 90% confluence (passage 0, P0); at P0, CFU-F were
counted by visual examination to evaluate the rMSC
number in the primary culture. Cells were then harvested
for further expansion and re-plated at 5000 cells/cm2. At
the end of each passage (90% confluence) cells were
counted. Cell Doubling (CD), Cumulative Population
Doublings (CPD) and Doubling Time (DT) values were
calculated following established formulae.
Osteogenic, chondrogenic and adipogenic differentiation
were performed following standard protocols.
Determination of influence of culture passage and plating 
density on cell proliferation and clonogenic potential
Aliquots of rMSC from different culture passages (P1, P2
and P3) were assayed for cell proliferation (fold increase),
and clonogenic ability (CFU-F assay).
Cells were plated at 10 cells/cm2, 100 cells/cm2 and 1000
cells/cm2 in SCM in 12-well tissue culture plates in dupli-
cate. Every day for a week, cells from each culture density
(in triplicate) were detached and counted in a haemocy-
tometer. Viability was assessed by 0.4% Trypan Blue
exclusion test. Fold increase was calculated dividing the
number of harvested cells at 90% confluence by the
number of plated cells.
To evaluate the clonogenic potential the CFU-F assay was
performed as follows: rMSC were seeded in SCM, at 10
cells/cm2, 100 cells/cm2 and 1000 cells/cm2 in 6-well tis-
sue culture plates. Colonies were counted on day 7 and
10. Cells were then stained with Crystal Violet (0.5%) in
methanol at RT for 10 minutes, washed twice with PBS
and visually counted.
Selection of different culture conditions and media for 
rMSC expansion and clonogenic ability
P3 cells were plated at 10 cells/cm2 and 100 cells/cm2
either in α-MEM, or DMEM, or Medium199 (M199), or
Mesenchymal Stem Cells Basal Medium (MSCBM). FCS
20%, Penicillin 100 U/mL, Streptomycin 0.1 mg/mL and
L-Glutamine 2 mM were added to α-MEM, DMEM and
M199. To evaluate the effects of growth factor supplemen-
tation, 10 ng/mL human Epidermal Growth Factor
(hEGF) or 10 ng/mL fibroblast growth factor (bFGF) or
insulin 5 ug/mL were added to all media, with the excep-
tion of MSCBM.
To assess the effects of different serum supplements, α-
MEM, DMEM and M199 containing Penicillin 100 U/mL,
Streptomycin 0.1 mg/mL and L-Glutamine 2 mM, were
supplemented either with 20% FCS or 10% FCS – 10%
Horse Serum (HS).
After expansion for 8 days cell were counted. Fold increase
and CFU-F number were calculated.
Epitope analysis of rMSC: FACS and immunochemical 
analyses
FACS analyses were performed on P3 cells by using anti-
MHC I, anti-MHC II, anti-CD14, anti-CD45, anti-CD44,
anti-β-1-integrin and anti-CD90 mouse monoclonal anti-
bodies. As secondary antibody a FITC goat anti mouse IgG
was used. P3 cells were used for immunohistochemistry.BMC Research Notes 2008, 1:53 http://www.biomedcentral.com/1756-0500/1/53
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As primary antibodies anti-β-1-integrin, anti-CD90, anti-
MHC I, anti-MHC II, anti-vimentin, anti-α-smooth-actin,
anti-cytokeratin, anti-desmin were used. Reactivity was
visualized by streptavidine-peroxidase method.
Results
Isolation, expansion and differentiation of rMSC
The average number of marrow cells collected was 2.6 ±
1.1 × 107 (n = 5). The CFU number calculated at P0 was
170 ± 72 (n = 5) and there was a positive correlation
between the number of collected cells and the amount of
obtained CFUs at P0 (r = 0.89 p < 0.01).
The average of rMSC from each explant at the end of P0
was 11.2 ± 4.9 × 105 (n = 5), corresponding to 12.7 popu-
lation doublings. The CPD (22.1 ± 1.69) positively corre-
lated with the number of CFU at P0 (r = 0.76 p < 0.01).
Chondrogenic, adipogenic and osteogenic differentiation
was achieved (Fig. 1).
Determination of influence of culture passage and plating 
density on cell proliferation (fold increase) and clonogenic 
potential (CFU-F assay) (Fig. 2)
Doubling time at P3 was always significantly lower than
at P1 and P5 (p < 0.001), and within each passage it was
significantly affected by cell density.
Fold increase value was in inverse relation to the number
of cells plated at each culture passage at all cell densities
(p < 0.001).
The number of CFU/1000 cells was in inverse relation to
the number of cells plated; in particular at P3 a significant
difference was observed at all cell densities (p < 0.01 10
cells/cm2 and 1000 cells/cm2, p < 0.05 100 cells/cm2),
while at P1 a significant difference was observed only at a
plating density of 10 cells/cm2. The number of CFU at P1
was significantly higher in comparison with the other pas-
sages at 1000 cells/cm2 (p < 0.001 vs. P5 and p < 0.01 vs.
P3), at 100 cells/cm2(p < 0.01 vs. P5, and p < 0.05 vs. P3)
and at 10 cells/cm2 (p < 0.01 vs. P5, and p < 0.05 vs. P3).
Effects of different culture conditions and media on rMSC 
expansion (Fig. 3A, B) and clonogenic ability (Fig. 3C, D)
With plating density of 10 cells/cm2 total fold increase
ranged from 80 to 100 in all media except than DMEM-
20%FCS which showed a 30-fold increase of cell number,
significantly lower (p < 0.05) than all other media. With a
plating density of 100 cells/cm2 the fold increase was
approximately 4–5 times lower in all media (p < 0.05 vs.
respective controls), and the fold increase of DMEM was
significantly lower than all other media (p < 0.01 vs α-
MEM, p < 0.05 vs MSCBM and M199).
In α-MEM and M199 and not in DMEM, proliferation was
significantly enhanced by EGF but not by insulin and FGF.
The effect was partially dependent on the plating density,
as it was observed in α-MEM and M199 at 100 cells/cm2
(p < 0.01 vs control). At 10 cells/cm2 a significant increase
(p < 0.01) was found in α-MEM. The cell growth of rMSC
in  α-MEM supplemented with EGF was significantly
higher than in MSCBM (p < 0.005) at 10 cell/cm2.
The substitution of 20%FCS with 10%FCS and 10%HS
caused a significant increase of cell proliferation in α-
MEM (p < 0.05) and DMEM (p < 0.05) at 100 cells/cm2.
At 10 cells/cm2 a significant decrease of fold increase was
found for DMEM (p < 0.05).
Culture media influenced the number of colonies formed,
the highest clonogenic ability being found at 100 cell/cm2
with MSCBM (p < 0.001) and at 10 cell/cm2 with M199 (p
< 0.05 vs. all other media). The lowest value was found in
DMEM both with 10 and 100 cells/cm2 (p < 0.05 and p <
0.001, respectively).
rMSC differentiated into chondrocyte, osteocyte, and adipocyte cells Figure 1
rMSC differentiated into chondrocyte, osteocyte, and adipocyte cells. Chondrogenic differentiation detected by Alcian blue 
staining (A), osteogenic differentiation detected by Alizarin Red staining (B), adipogenic differentiation detected by Oil Red O 
staining (C) at light microscopy.BMC Research Notes 2008, 1:53 http://www.biomedcentral.com/1756-0500/1/53
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Both at 10 cells/cm2 and 100 cells/cm2 in  α-MEM the
highest increase of CFU was found with FGF, which
showed to be superior to EGF (p < 0.001 at 100 cell/cm2
and p < 0.05 at 10 cell/cm2) and insulin (p < 0.001 at 100
cells/cm2 and p < 0.01 at 10 cells/cm2). M199 showed a
significant increase of CFU (p < 0.05 in 100 cell/cm2 e p <
0.05 in 10 cell/cm2) when supplemented with FGF.
The clonogenic ability of rMSC in α-MEM supplemented
with FGF was significantly higher than in MSCBM (p <
0.0001 both at 100 cells/cm2 and 10 cells/cm2).
All media, supplemented with 10%FCS – 10%HS pro-
duced a significant increase of CFU (p < 0.05).
Epitope analysis of rMSC: FACS and immunochemical 
analyses
rMSC from all animals were positive for CD29, and
CD44. They did not express monocyte-macrophage anti-
gens such as CD14 and CD45. The adherent cells were
negative for MHC I and MHC II. Immunohistochemical
analysis confirmed the positivity for CD29 and the nega-
tivity for CD90, MHC I and MHC II. rMSC resulted posi-
Effect of plating density and culture passage on rMSC doubling time, clonogenic ability and expansion potential Figure 2
Effect of plating density and culture passage on rMSC doubling time, clonogenic ability and expansion potential.BMC Research Notes 2008, 1:53 http://www.biomedcentral.com/1756-0500/1/53
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tive for vimentin, α-smooth actin and desmin while they
were negative for cytokeratin, as showed in table 1 in com-
parison with data already reported for humans and
rodents.
Discussion
We found that at both 10 and 100 cells/cm2 plating den-
sity was significantly lower with DMEM than α-MEM. In
all basal media the decrease of cell density improved fold
increase; moreover with the exception of MSCBM this
improvement was followed by a proportional increase of
clonogenic ability. The average number of cells formed by
each clone at both plating densities remained substan-
tially the same. In MSCBM we observed a significant
improvement of fold increase at 10 cells/cm2 while no
substantial variation was found on the clonogenic ability.
Therefore in this case the highest cell number seems to
depend on a greater proliferation rate of the clonogenic
units.
Evaluation of the effects of culture media, serum and growth factors on rMSC Figure 3
Evaluation of the effects of culture media, serum and growth factors on rMSC. A: fold increase at 10 cells/cm2; B: fold increase 
at 100 cells/cm2; C: CFU number at 10 cells/cm2; D: CFU number at 100 cells/cm2. * = significantly different from the other 
basal media w/o supplements; ε = significantly different from the corresponding basal medium w/o supplements; § = signifi-
cantly different from the corresponding medium at 10 cells/cm2 plating density.BMC Research Notes 2008, 1:53 http://www.biomedcentral.com/1756-0500/1/53
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In terms of clonogenic ability, 10%FCS – 10%HS supple-
menting performed significantly better than 20%FCS
when cells were grown in α-MEM, M199 or DMEM at
both plating densities; the same performance enhance-
ment was not always detectable for cell proliferation.
EGF was able to enhance the fold increase, the highest per-
formance being found with α-MEM+EGF at 10 cells/cm2.
This latter information suggests that cell density strongly
influences the culture requirements of rMSC and low-cell
density plating minimizes the requirement of supple-
ments.
We also found that the expansibility of rMSC was predict-
able on the basis of a CFU-F assay, likely reflecting the
number of rMSC in the bone marrow sample, as already
suggested [12,13]. The strong positive correlation found
in our study between CFU-F number at P0 and population
doublings confirms that CFU-F assay can be useful for pre-
dicting the cell suitability for extensive expansion.
As reported for humans [5], rats [7] and mice [14] we
found that rMSC expansion increased dramatically when
cells were plated at low density: this might be due to an
higher cell-to-cell contact inhibition or factors synthe-
sized as a consequence of higher cell concentration able to
decrease the proliferative ability of the population [15].
Moreover, in the first passages, we found that the clono-
genic ability of rMSC was in inverse relation to the plating
density. The doubling time decreased from P1 to P3 and
it could depend on the progressive increase of rapidly
dividing rMSC which are thought to represent a minute
fraction of the cells plated in the first passages [16].
We observed at least two morphologically distinct cells:
spindle shaped and broad cells, corresponding to the pre-
viously described type I and type II cells [17,18].
It has been reported that CD90 and MHC I are generally
expressed in mesenchymal stromal cells [19], and CD90
expression shows a great variability [14]. Recently it has
been reported that mesenchymal progenitors in the
umbilical cord do not express MHC I under particular
conditions [20]. In our study CD90 and MHC I were both
negative. The variability of the reported surface markers
on mesenchymal cells may depend on different stage of
commitment, or just on the ex-vivo culturing conditions.
The immunoreactivity obtained against CD44, CD29,
desmin, vimentin and α-smooth actin, as well as the neg-
ative reaction for CD14, CD45, MHC II, cytokeratin con-
cord with data reported for humans and rodents.
Taken together, our data suggest that different progenitor
cells with differential sensitivity to media, sera and growth
factors exist and may be expanded in selected conditions.
The choice of culture media, supplements and serum
compositions has to be carefully considered to expand
rMSC since it can lead to considerable variation in yield
and CFU number.
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